Breaking News, Financial News

Financial Report: Catalent Pharma Solutions

Catalent Pharma Solutions

2Q Revenues: $464 million (+11%)

2Q Loss: $30.2 million (earnings were $18.5 million 4Q06)

YTD Revenues: $902 million (+11%)

YTD Loss: $41.5 million (earnings were $19.6 million YTD06)

Comments: Revenue growth was primarily due to demand for Oral Technologies pharmaceutical products and increased volumes and throughput in the Sterile Technologies segment, including increased output from the new sterile facility in Belgium. Oral Technologies revenue in the quarter was $256.9 million (+11%). Sterile Technologies revenue in the quarter was $74.1 million (+22%) Packaging Services revenue was $143.7 million (+7%). The weaker U.S. dollar favorably impacted revenue growth by approximately 6%. Results in the quarter include the impact of purchase accounting adjustments of $2.1 million.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters